ursodeoxycholic acid has been researched along with Schistosoma mansoni Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Claudel, T; Engelmann, R; Fickert, P; Fuchs, CD; Guenther, ND; Langner, C; Loebermann, M; Mueller, M; Mueller-Hilke, B; Österreicher, CH; Reisinger, EC; Sahin, E; Schramm, C; Schwinge, D; Sombetzki, M; Trauner, M | 1 |
| Borges, DR; de J Ribeiro, P; de Toledo, CF; Narciso, JL | 1 |
2 other study(ies) available for ursodeoxycholic acid and Schistosoma mansoni Infection
| Article | Year |
|---|---|
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
Topics: Animals; Cholagogues and Choleretics; Disease Models, Animal; Drug Monitoring; Granuloma; Immunohistochemistry; Inflammation; Liver Cirrhosis; Lymphocyte Activation; Mice; Schistosomiasis mansoni; T-Lymphocytes; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Gamma-glutamyltransferase decreases in patients with the chronic form of schistosomiasis mansoni treated with ursodeoxycholic acid.
Topics: Adult; Chronic Disease; Female; gamma-Glutamyltransferase; Humans; Male; Prospective Studies; Schistosomiasis mansoni; Ursodeoxycholic Acid | 2005 |